Variable | No response | Response | OR (95% CI)a |
---|---|---|---|
N (%) | 10 (19.6) | 41 (80.4) | – |
Age (year) | 38.2 ± 21.9 | 37.8 ± 19.4 | 1.001 (0.97–1.04) |
Gender (%) male | 6 (60.0) | 26 (63.4) | 1.15 (0.28–4.77) |
MAP (mmHg) | 99.6 ± 17.6 | 90.3 ± 18.5 | 1.05 (0.99–1.12) |
BMI (kg/m2) | 26.2 ± 5.5 | 24.4 ± 5.1 | 1.07 (0.93–1.22) |
Ln(Pro) (g/24 h) | 2.1 ± 0.4 | 2.0 ± 0.4 | 1.53 (0.30–7.79) |
Albumin (g/L) | 17.0 ± 6.7 | 14.3 ± 5.5 | 1.10 (0.97–1.25) |
eGFR (mL/min/1.73 m2) | 103.5 ± 20.2 | 102.3 ± 30.6 | 1.003 (0.97–1.03) |
TG (mmol/L) | 3.1 ± 2.2 | 3.2 ± 1.8 | 0.98 (0.66–1.47) |
TC (mmol/L) | 8.5 ± 3.8 | 10.2 ± 3.1 | 0.79 (0.60–1.05) |
Ln(MAU) (mg/L) | 7.9 ± 1.3 | 8.5 ± 1.2 | 0.62 (0.34–1.13) |
Ln(ORM) (mg/g Cr) | 5.0 ± 1.2 | 5.6 ± 1.0 | 0.55 (0.27–1.15) |
Ln(RBP) (mg/L) | − 1.1 ± 1.7 | − 0.7 ± 1.7 | 0.85 (0.55–1.33) |
Ln(β2-MG) (ug/L) | 6.6 ± 1.8 | 5.7 ± 1.4 | 1.89 (1.02–3.53)# |
Ln(α1-MG) (mg/dL) | 1.6 ± 0.9 | 1.3 ± 1.0 | 1.40 (0.63–3.04) |
Pathology | |||
FSGS (%) | 5 (45.5) | 6 (54.5) | 5.83 (1.29–26.46)* |
MCD (%) | 5 (12.5) | 35 (87.5) | 0.17 (0.04–0.78)* |